EMA CHMP have today recommended market authorisation of Valneva COVID19 vaccine in the EU. Another step forward for this vaccine thanks to work done by research teams in the UK and thousands of UK study participants. valneva.com/press-release/…

Valneva Phase I/II trial peer review publication now out. Dose finding vs NeutABs, low reactogenicity, broad Cell mediated responses. Vaccine now licensed/authorised in EU/UK. Thanks to all sites and participants. sciencedirect.com/science/articl…

Final peer-reviewed publication on interim analysis of Valneva phase 3 trial that supported MHRA and EMA approval now available at: sciencedirect.com/science/articl…

Our latest preprint, estimating effectiveness of BNT162b2 COVID-19 Vaccination in Prevention of Hospitalisations and Severe Disease in Adults with Delta & Omicron SARS-CoV-2 Infection Leon Adam Finn Anastasia Chatzilena @rjchallen papers.ssrn.com/sol3/papers.cf…

Bristol Vaccine Centre vacancy for clinical research manager. Closing date 12th October. Please forward to anyone you know who might be interested bristol.ac.uk/jobs/find/deta… Informal enquiries to [email protected]

jitsuvax.info is now live. Understanding vaccine hesitancy. Helping “immunise” people against misinformation.

RIP Sam Katz a giant of vaccinology pediatrics.duke.edu/news/rememberi…

JCVI recs on 2023 spring booster now published: gov.uk/government/pub…

Do you work with bovine tuberculosis (bTB)-infected cattle? If yes Bristol Population Health Science Institute wants you to take part in the ZooTB study. Come to The White Hart, Congresbury on Monday 13 March to find out more and sign up. 👉 fal.cn/3ws2E #bovineTB Ellen Brooks Pollock  Amy Thomas

Do #bivalent mRNA boosters offer equivalent protection to monovalent mRNA #COVID19 #vaccines? We try to answer this in our new #COVIDVACCINE paper from #avoncap Bristol UNCOVER Group Bristol Academic Respiratory Unit Research at North Bristol NHS Trust Adam Finn Anastasia Chatzilena Leon medrxiv.org/content/10.110…

Trends in serotype distribution and disease severity in adults hospitalised with Streptococcus pneumoniae infection in Bristol and Bath: a retrospective cohort study, 2006-2022 medrxiv.org/cgi/content/sh… #medRxiv

Latest pre-print from the Bristol UNCOVER group - working towards a thermostable protein nanoparticle vaccine "ADDomer" against COVID19 biorxiv.org/content/10.110…

First ever RSV vaccine licensed by FDA. This one is for elderly adults. After years of no options for RSV suddenly there is about to be a plethora of tools to prevent it both in infants and old people gsk.com/en-gb/media/pr…

New from the UNCOVER group which made use of samples stored pre-pandemic in the Bristol Biobank. The capacity of COVID19 vaccines to induce mucosal immune responses so far has been disappointing - more attention to salivary IgA responses needed in future doi.org/10.1038/s43856…

doi: doi.org/10.1038/d41586…

Simplify manuscript submissions in academic journals! - Sign the Petition! chng.it/v267T74m via Change.org UK

🔬 Exciting New Podcast! 🎧 Join us for a captivating episode where we delve into Pediatric Infectious Diseases with Sir Andrew Pollard & Prof. Adam Finn. Discover how the pandemic affected children & gain unique insights. Adam Finn | Department of Paediatrics Listen now!